# A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

> **NCT00820768** · PHASE1 · WITHDRAWN · sponsor: **Celgene**

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** ABI-010

## Key facts

- **NCT ID:** NCT00820768
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-04-01
- **Primary completion:** 2013-04-01
- **Final completion:** 2014-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820768, "A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00820768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*